Form 4: Vaxcyte CFO Reports Stock Transaction
Insider Transaction (Form 4)
Andrew Guggenhime, PRESIDENT AND CFO of Vaxcyte, Inc., reported a transaction in 7,155 shares of common stock on September 8, 2026.
Summary
- Tax/exercise-price withholding: disposed of 7,155 Common Stock at $60.36 ($431,876) on September 8, 2026; holds 95,316 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Andrew Guggenhime — Officer (PRESIDENT AND CFO)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-08 | Tax/exercise-price withholding | Common Stock | 7,155 | $60 | $431.9K | 95,316 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-08 | Tax/exercise-price withholding (7,155 shares) |
Keywords
insider transaction, Form 4, PCVX, Vaxcyte, Inc., neutral, Andrew Guggenhime
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.